ArticleCureus2026
Seronegative Autoimmune Encephalitis: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune encephalitis is an inflammatory disorder of the central nervous system frequently associated with antibodies directed against neuronal surface or intracellular antigens. However, a substantial subset of patients remains seronegative, posing diagnostic challenges. We report the case of a 65-year-old man who presented to the emergency department with acute confusion, prosopagnosia, psychomotor agitation, and generalized tonic-clonic seizures, followed by coma requiring intubation and intensive care admission. Extensive microbiological findings, including CSF PCR for herpes simplex virus (HSV) and varicella-zoster virus (VZV) and CSF cultures, as well as a comprehensive autoimmune encephalitis panel in serum and CSF (anti-NMDA, anti-AMPA, anti-GABA, anti-LGI1, anti-CASPR2, anti-DPPX), were all negative. Brain magnetic resonance imaging demonstrated faint diffuse cortical hyperintensity on diffusion-weighted imaging, more pronounced in the temporo-parietal regions, without contrast enhancement. Electroencephalography revealed diffuse epileptiform activity. Based on clinical presentation, neuroimaging findings, exclusion of alternative etiologies, and electroencephalographic abnormalities, a diagnosis of probable seronegative autoimmune encephalitis was established. The patient was treated with high-dose intravenous methylprednisolone followed by intravenous immunoglobulins, resulting in rapid neurological improvement and complete recovery (modified Rankin Scale (mRS) score of 1 upon discharge from the hospital). This case highlights the importance of clinical judgment in suspected autoimmune encephalitis, even in the absence of detectable neuronal antibodies, and underscores the potential for favorable outcomes with early immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.